CLOZAPINE FOR TREATMENT-RESISTANT SCHIZOPHRENIA - CANADIANS REGULATIONS AND GUIDELINES

被引：0
作者：
COLLINS, EJ
LALONDE, P
JONES, BD
ADDINGTON, D
MACCRIMMON, DJ
MACEWEN, GW
TEEHAN, MD
机构：
[1] UNIV TORONTO, DEPT PSYCHIAT, TORONTO M5S 1A1, ONTARIO, CANADA
[2] UNIV MONTREAL, DEPT PSYCHIAT, MONTREAL H3C 3J7, QUEBEC, CANADA
[3] UNIV OTTAWA, DEPT PSYCHIAT, OTTAWA K1N 6N5, ONTARIO, CANADA
[4] MCMASTER UNIV, DEPT PSYCHIAT, HAMILTON L8S 4L8, ONTARIO, CANADA
[5] UNIV CALGARY, DEPT PSYCHIAT, CALGARY T2N 1N4, ALBERTA, CANADA
[6] UNIV BRITISH COLUMBIA, DEPT PSYCHIAT, VANCOUVER V6T 1W5, BC, CANADA
[7] DALHOUSIE UNIV, DEPT PSYCHIAT, HALIFAX B3H 4H2, NS, CANADA
来源：
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE | 1992年 / 37卷 / 07期
关键词：
D O I：
10.1177/070674379203700705
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：489 / +
页数：1
相关论文
共 24 条
  • [1] ANDERSON ES, 1991, J CLIN PSYCHIAT, V52, P102
  • [2] BALDESSARINI RJ, 1991, NEW ENGL J MED, V324, P746
  • [3] CLAGHORN J, 1987, J CLIN PSYCHOPHARM, V7, P377
  • [4] COLLINS EJ, 1992, ROYAL SOC MED INT C, V185, P55
  • [5] CLOZAPINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES, AND THERAPEUTIC USE IN SCHIZOPHRENIA
    FITTON, A
    HEEL, RC
    [J]. DRUGS, 1990, 40 (05) : 727 - 747
  • [6] HALLER E, 1990, AM J PSYCHIAT, V147, P1069
  • [7] HONIGFELD G, 1990, HOSP COMMUNITY PSYCH, V41, P882
  • [8] KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789
  • [9] LEADBETTER R, 1992, AM J PSYCHIAT, V149, P68
  • [10] CLOZAPINE PHARMACOLOGY AND TARDIVE-DYSKINESIA
    LIEBERMAN, J
    JOHNS, C
    COOPER, T
    POLLACK, S
    KANE, J
    [J]. PSYCHOPHARMACOLOGY, 1989, 99 : S54 - S59
123